Statistics for Editas Medicine (id:7957 EDIT)

Valuation metrics

Market cap

219.58M

Enterprise value

-7,022,056.00

Trailing P/E (ttm)

-1.21

Forward P/E

-1.13

PEG ratio

-1.13

Price/Sales (ttm)

3.56

Price/Book (mrq)

1.25

Enterprise Value/Revenue

-0.11

Enterprise Value/EBITDA

0.03

Overview

Shares outstanding

82.55M

Float

76.22M

Shares short

17.24M

% Held by insiders

0.00%

% Held by institutions

0.70%

Average volume (10 days)

2.33M

Average volume (90 days)

Price summary

52-Week low

2.30

52-Week high

11.69

52-Week change

-336.68%

Beta

2.01

50-Day moving average

3.33

200-Day moving average

5.31

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-107,649.18%

Operational effectiveness

Return on assets

-34.32%

Return on equity

-78.56%

Income statement

Revenue (ttm)

0.75

Revenue per share (ttm)

0.75

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-222,627,008.00

Net income to common (ttm)

-210,572,000.00

Diluted EPS (ttm)

-2.54

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

265.09M

Total cash per share (mrq)

3.21

Total debt (mrq)

38.49M

Total Debt/Equity (mrq)

21.91

Current ratio (mrq)

374.70%

Book value per share (mrq)

2.13

Cash flow

Cash flow statement

-181,762,000.00

Levered free cash flow (LFCF)

-113,797,624.00